{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:05Z","timestamp":1790188265682,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity is often associated with increased risk of cardiovascular diseases. Previous studies suggest that epidermal growth factor receptor (EGFR) antagonism may be effective for the treatment of angiotensin II-induced cardiac hypertrophy and diabetic cardiomyopathy. This study was performed to demonstrate if EGFR plays a role in the pathogenesis of hyperlipidemia\/obesity-related cardiac injuries. The <jats:italic>in vivo<\/jats:italic> studies using both wild type (WT) and apolipoprotein E (ApoE) knockout mice fed with high fat diet (HFD) showed the beneficial effects of small-molecule EGFR inhibitors, AG1478 and 542, against obesity-induced myocardial injury. Administration of AG1478 and 542 significantly reduced myocardial inflammation, fibrosis, apoptosis and dysfunction in both two obese mouse models. <jats:italic>In vitro<\/jats:italic>, EGFR signaling was blocked by either siRNA silencing or small-molecule EGFR inhibitors in palmitic acid (PA)-stimulated cardiomyocytes. EGFR inhibition attenuated PA-induced inflammatory response and apoptosis in H9C2 cells. Furthermore, we found that PA-induced EGFR activation was mediated by the upstream TLR4 and c-Src. This study has confirmed the detrimental effect of EGFR activation in the pathogenesis of obesity-induced cardiac inflammatory injuries in experimental mice and has demonstrated the TLR4\/c-Src-mediated mechanisms for PA-induced EGFR activation. Our data suggest that EGFR may be a therapeutic target for obesity-related cardiovascular diseases.<\/jats:p>","DOI":"10.1038\/srep24580","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T09:35:47Z","timestamp":1460972147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Weixin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"key":"BFsrep24580_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3945\/an.115.010587","volume":"7","author":"LK Brahe","year":"2016","unstructured":"Brahe, L. K., Astrup, A. & Larsen, L. H. Can we prevent obesity-related metabolic diseases by dietary modulation of the gut microbioba? Adv Nutr 7, 90\u2013101 (2016).","journal-title":"Adv Nutr"},{"key":"BFsrep24580_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11, 886\u2013895 (2011).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep24580_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert, H. B., Feinleib, M., McNamara, P. M. & Castelli, W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67, 968\u2013977 (1983).","journal-title":"Circulation"},{"key":"BFsrep24580_CR4","doi-asserted-by":"publisher","first-page":"14014","DOI":"10.1038\/srep14014","volume":"5","author":"K Cao","year":"2015","unstructured":"Cao, K. et al. Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation. Sci Rep 5, 14014 (2015).","journal-title":"Sci Rep"},{"key":"BFsrep24580_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tcm.2014.09.005","volume":"25","author":"R Mahajan","year":"2015","unstructured":"Mahajan, R., Lau, D. H. & Sanders, P. Impact of obesity on cardiac metabolism, fibrosis and function. Trends Cardiovasc Med 25, 119\u2013126 (2015).","journal-title":"Trends Cardiovasc Med"},{"key":"BFsrep24580_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.tcm.2014.09.010","volume":"25","author":"JA Leopold","year":"2015","unstructured":"Leopold, J. A. Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease. Trends Cardiovasc Med 25, 127\u2013128 (2015).","journal-title":"Trends Cardiovasc Med"},{"key":"BFsrep24580_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pupt.2005.04.005","volume":"19","author":"HW Chan","year":"2006","unstructured":"Chan, H. W., Smith, N. J., Hannan, R. D. & Thomas, W. G. Tackling the EGFR in pathological tissue remodelling. Pulm Pharmacol Ther 19, 74\u201378 (2006).","journal-title":"Pulm Pharmacol Ther"},{"key":"BFsrep24580_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrd3297","volume":"9","author":"F Grimminger","year":"2010","unstructured":"Grimminger, F., Schermuly, R. T. & Ghofrani, H. A. Targeting non-malignant disorders with tyrosine kinase inhibitors. Nat Rev Drug Discov 9, 956\u2013970 (2010).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep24580_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.ijcard.2014.07.161","volume":"176","author":"S Patane","year":"2014","unstructured":"Patane, S. ERBB1\/EGFR and ERBB2 (HER2\/neu)\u2013targeted therapies in cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol 176, 1301\u20131303 (2014).","journal-title":"Int J Cardiol"},{"key":"BFsrep24580_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1101\/gad.8.4.399","volume":"8","author":"NC Luetteke","year":"1994","unstructured":"Luetteke, N. C. et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8, 399\u2013413 (1994).","journal-title":"Genes Dev"},{"key":"BFsrep24580_CR11","doi-asserted-by":"publisher","first-page":"H65","DOI":"10.1152\/ajpheart.00866.2008","volume":"297","author":"CJ Barrick","year":"2009","unstructured":"Barrick, C. J. et al. Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL\/6J but not 129S1\/SvImJ mice. Am J Physiol Heart Circ Physiol 297, H65\u201375 (2009).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep24580_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2005.06.038","volume":"186","author":"AC Dreux","year":"2006","unstructured":"Dreux, A. C., Lamb, D. J., Modjtahedi, H. & Ferns, G. A. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 186, 38\u201353 (2006).","journal-title":"Atherosclerosis"},{"key":"BFsrep24580_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.RES.0000240147.49390.61","volume":"99","author":"P Zhai","year":"2006","unstructured":"Zhai, P. et al. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res 99, 528\u2013536 (2006).","journal-title":"Circ Res"},{"key":"BFsrep24580_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/01.HYP.0000047104.42047.9B","volume":"41","author":"S Kagiyama","year":"2003","unstructured":"Kagiyama, S., Qian, K., Kagiyama, T. & Phillips, M. I. Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy. Hypertension 41, 824\u2013829 (2003).","journal-title":"Hypertension"},{"key":"BFsrep24580_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/01.RES.84.9.1073","volume":"84","author":"Y Moriguchi","year":"1999","unstructured":"Moriguchi, Y. et al. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ Res 84, 1073\u20131084 (1999).","journal-title":"Circ Res"},{"key":"BFsrep24580_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","volume":"82","author":"D Liang","year":"2015","unstructured":"Liang, D. et al. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. J Mol Cell Cardiol 82, 63\u201374 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"BFsrep24580_CR17","unstructured":"Peng, K. et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced 1 by angiotensin II. J Cell Mol Med, 10.1111\/jcmm.12763 (2016)."},{"key":"BFsrep24580_CR18","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1161\/ATVBAHA.112.256107","volume":"32","author":"B Stanic","year":"2012","unstructured":"Stanic, B. et al. Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler Thromb Vasc Biol 32, 2452\u20132460 (2012).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep24580_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2567.2008.02892.x","volume":"126","author":"A Schaeffler","year":"2009","unstructured":"Schaeffler, A. et al. Fatty acid-induced induction of Toll-like receptor-4\/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126, 233\u2013245 (2009).","journal-title":"Immunology"},{"key":"BFsrep24580_CR20","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland, W. L. et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121, 1858\u20131870 (2011).","journal-title":"J Clin Invest"},{"key":"BFsrep24580_CR21","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1074\/jbc.M110.154823","volume":"286","author":"D Thuringer","year":"2011","unstructured":"Thuringer, D. et al. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. J Biol Chem 286, 3418\u20133428 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep24580_CR22","doi-asserted-by":"publisher","first-page":"32369","DOI":"10.1074\/jbc.M805053200","volume":"283","author":"S Basu","year":"2008","unstructured":"Basu, S. et al. Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells. J Biol Chem 283, 32369\u201332376 (2008).","journal-title":"J Biol Chem"},{"key":"BFsrep24580_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0006-291X(02)02197-6","volume":"297","author":"N Tanaka","year":"2002","unstructured":"Tanaka, N. et al. A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun 297, 375\u2013381 (2002).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep24580_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.112.192500","volume":"60","author":"M Gal\u00e1n","year":"2012","unstructured":"Gal\u00e1n, M. et al. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension 60, 71\u201380 (2012).","journal-title":"Hypertension"},{"key":"BFsrep24580_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker, R. G., Hayden, M. S. & Ghosh, S. NF-kappaB, inflammation and metabolic disease. Cell Metab 13, 11\u201322 (2011).","journal-title":"Cell Metab"},{"key":"BFsrep24580_CR26","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.2741\/3506","volume":"14","author":"T Glaros","year":"2009","unstructured":"Glaros, T., Larsen, M. & Li, L. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci (Landmark Ed) 14, 3988\u20133993 (2009).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"BFsrep24580_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/emm.2007.41","volume":"39","author":"GY Hur","year":"2007","unstructured":"Hur, G. Y. et al. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med 39, 367\u2013375 (2007).","journal-title":"Exp Mol Med"},{"key":"BFsrep24580_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.RES.85.10.892","volume":"85","author":"N Vacaresse","year":"1999","unstructured":"Vacaresse, N. et al. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res 85, 892\u2013899 (1999).","journal-title":"Circ Res"},{"key":"BFsrep24580_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/bj2780679","volume":"278","author":"X Casabiell","year":"1991","unstructured":"Casabiell, X., Pandiella, A. & Casanueva, F. F. Regulation of epidermal-growth-factor-receptor signal transduction by cis-unsaturated fatty acids. Evidence for a protein kinase C-independent mechanism. Biochem J 278 (Pt 3), 679\u2013687 (1991).","journal-title":"Biochem J"},{"key":"BFsrep24580_CR30","doi-asserted-by":"publisher","first-page":"16683","DOI":"10.1074\/jbc.M011695200","volume":"276","author":"JY Lee","year":"2001","unstructured":"Lee, J. Y., Sohn, K. H., Rhee, S. H. & Hwang, D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276, 16683\u201316689 (2001).","journal-title":"J Biol Chem"},{"key":"BFsrep24580_CR31","doi-asserted-by":"publisher","first-page":"31736","DOI":"10.1074\/jbc.M803732200","volume":"283","author":"DA Bergin","year":"2008","unstructured":"Bergin, D. A. et al. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem 283, 31736\u201331744 (2008).","journal-title":"J Biol Chem"},{"key":"BFsrep24580_CR32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/labinvest.2010.100","volume":"90","author":"D Hsu","year":"2010","unstructured":"Hsu, D. et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab Inves 90, 1295\u20131305 (2010).","journal-title":"Lab Inves"},{"key":"BFsrep24580_CR33","doi-asserted-by":"publisher","first-page":"9680","DOI":"10.1073\/pnas.1511794112","volume":"112","author":"S De","year":"2015","unstructured":"De, S. et al. Erlotinib protects against LPS-induced endotoxicity becaused TLR4 needs EGFR to signal. Proc Natl Acad Sci USA 112, 9680\u20139685 (2015).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep24580","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:52:13Z","timestamp":1672843933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep24580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,18]]}},"alternative-id":["BFsrep24580"],"URL":"https:\/\/doi.org\/10.1038\/srep24580","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,18]]},"assertion":[{"value":"7 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24580"}}